Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.

In a large trial, the approved therapy Winrevair showed confirmed benefits for CpcPH-HFpEF, a type of PH associated with ...

Winrevair is now covered by several public drug programs in Canada, expanding access for eligible people with PAH.

Cereno’s CS1 was well tolerated after one year in people with PAH in an expanded access program, with results consistent with ...

The proportion of people in the U.S. with PAH related to methamphetamine use increased by 93% between 2018 and 2022, a study ...

Ten years after his pulmonary hypertension diagnosis, columnist Mike Naple reflects on what he's learned about strength.

As a lifelong patient, columnist Anna Jeter has seen many inaccuracies on TV medical dramas. "The Pitt" is a big improvement, ...

A naturally occurring signaling molecule called C-type natriuretic peptide, or CNP, was shown to reduce the severity of PAH.

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Pulmonary hypertension is a rare lung disease characterized by increased blood pressure in the pulmonary arteries that eventually makes breathing very difficult. Breathing is the most important thing ...

Pulmonary hypertension (PH) is characterized by high blood pressure, which affects the pulmonary arteries, the vessels that transport blood from the heart to the lungs. Due to the thickened and ...